Karen K Winer

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium
    Karen K Winer
    the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892 7510, USA
    J Clin Endocrinol Metab 95:2680-8. 2010
  2. ncbi Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism
    Karen K Winer
    the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland 20892 7510, USA
    J Clin Endocrinol Metab 97:391-9. 2012
  3. ncbi Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium
    Karen K Winer
    Pediatric and Reproductive Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Clin Endocrinol Metab 88:4214-20. 2003
  4. ncbi Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism
    Karen K Winer
    National Institute of Child Health and Human Development, National Institutes of Health, Building 6100, Room 4B11, Bethesda, Maryland 20892 7510, USA
    J Clin Endocrinol Metab 93:3389-95. 2008
  5. ncbi PTH(1-34) replacement therapy in a child with hypoparathyroidism caused by a sporadic calcium receptor mutation
    Todd A Theman
    Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA
    J Bone Miner Res 24:964-73. 2009
  6. ncbi Fibroblast growth factor-23 is regulated by 1alpha,25-dihydroxyvitamin D
    Michael T Collins
    Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892 4320, USA
    J Bone Miner Res 20:1944-50. 2005
  7. ncbi A puzzling case of anemia
    Salim A Haddad
    Department of Transfusion Medicine, National Institutes of Health, Warren G Magnusson Clinical Center, Bethesda, Maryland 20892, USA
    Transfusion 42:1610-3. 2002

Collaborators

Detail Information

Publications7

  1. ncbi Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium
    Karen K Winer
    the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892 7510, USA
    J Clin Endocrinol Metab 95:2680-8. 2010
    ..This is the first randomized controlled study in children comparing treatment with synthetic human PTH 1-34 and calcitriol...
  2. ncbi Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism
    Karen K Winer
    the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland 20892 7510, USA
    J Clin Endocrinol Metab 97:391-9. 2012
    ..An alternative approach, PTH 1-34 administered twice daily, provides acceptable long-term treatment but is associated with nonphysiological serum calcium fluctuation...
  3. ncbi Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium
    Karen K Winer
    Pediatric and Reproductive Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Clin Endocrinol Metab 88:4214-20. 2003
    ....
  4. ncbi Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism
    Karen K Winer
    National Institute of Child Health and Human Development, National Institutes of Health, Building 6100, Room 4B11, Bethesda, Maryland 20892 7510, USA
    J Clin Endocrinol Metab 93:3389-95. 2008
    ..Hypoparathyroidism is among the few hormonal insufficiency states not treated with replacement of the missing hormone. Long-term conventional therapy with vitamin D and analogs may lead to nephrocalcinosis and renal insufficiency...
  5. ncbi PTH(1-34) replacement therapy in a child with hypoparathyroidism caused by a sporadic calcium receptor mutation
    Todd A Theman
    Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA
    J Bone Miner Res 24:964-73. 2009
    ..Additionally, this may be the first evidence of a role for CaR in human bone...
  6. ncbi Fibroblast growth factor-23 is regulated by 1alpha,25-dihydroxyvitamin D
    Michael T Collins
    Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892 4320, USA
    J Bone Miner Res 20:1944-50. 2005
    ..In addition, the phosphaturic effect of FGF-23 may be diminished in the absence of PTH action on the kidney...
  7. ncbi A puzzling case of anemia
    Salim A Haddad
    Department of Transfusion Medicine, National Institutes of Health, Warren G Magnusson Clinical Center, Bethesda, Maryland 20892, USA
    Transfusion 42:1610-3. 2002
    ..When the clinical course is complicated by sudden, severe declines in Hb concentration, the cause, nature, and lo- cation of bleeding may require an extensive clinical evaluation...